If 2020 was a tough year for legal departments, 2021, which started just weeks after health care workers began receiving the first COVID-19 vaccine doses in the country, seemed to promise much-needed relief from the pandemic—and even a semblance of normalcy.

But as the vaccines became increasingly accessible throughout the year, they introduced a whole new set of issues that left in-house counsel as busy as ever. With litigation on key vaccination questions pending and the possibility of more policy changes on the horizon, in-house counsel are going into 2022 with one clear-eyed expectation: There will be more challenges.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]